Implementation of Video-Consent in Clinical Research, Understanding of Consent in Clinical Research
Conditions
Brief summary
This pilot randomized controlled trial evaluates the impact of video-enhanced consent compared to the usual approach. The investigators aim to assess if video-enhanced consent empowers decision-making and improves understanding in parents considering participation in the ViDES study, which investigates the effectiveness of Vitamin D supplementation in extremely preterm infants (the ViDES study is separately registered as NCT05459298).
Interventions
OTHERViDEO explaining study
The research team will introduce themselves and ask the parents to watch an informational video explaining the ViDES study on an iPad while they stay in the room with the parents. After viewing the video, the team will answer any questions and provide written consent and enough time to decide whether to participate in the study. The research team will also provide a QR code that grants parents/guardians access to the video on their own device at any time. This allows them to pause, rewind, and revisit the information.
OTHERUsual Care
The research team will present a detailed explanation of the ViDES study, answer questions, provide written consent, and provide enough time to decide on participation or not in the study.
Sponsors
The University of Texas Health Science Center, Houston
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Parents/legal guardians of extremely preterm infants (\<28 weeks gestational age or \<1000 g birth weight) admitted to the Neonatal Intensive Care Unit at Children's Memorial Hermann hospital that qualify for the ViDES study (ViDES study is separately registered as NCT05459298)
Exclusion criteria
* Parents/legal guardians deaf or blind * Parents/legal guardians unable to consent for the VIDES study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ViDES trial consent rate | Within 1 week of the intervention | — |
| Participants' understanding of the ViDES study as assessed by a questionnaire | Within 48 hours of the intervention | The questionnaire assesses recall of possible benefits and risks of participation. |
| Participants' satisfaction with consent approach as assessed by a questionnaire | Within 48 hours of the intervention | The questionnaire assesses satisfaction with ability to ask questions and decision time. |
| Participant's opinions related to participation in research as assessed by a questionnaire | Within 48 hours of the intervention | The questionnaire assesses participant's opinions related to participation in research and research being part of the care of infants. |
Countries
United States
Outcome results
None listed